December 31, 2025 – PRESSADVANTAGE – As pharmaceutical development becomes increasingly global and highly regulated, pharmacovigilance translation has moved from a supporting function to a central ...
A new proposal in JAMA Internal Medicine suggests that the FDA should create an approval pathway for medical AI tools that parallels how physicians are trained and licensed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback